When I first heard about Dragen, it sounded interesting but recently Edico has started to make this platform available on AWS, as well as several Bioinformatics-as-a-service platforms, including DNANexus, Seven Bridges and Illumina's BaseSpace:
http://edicogenome.com/dragen-in-the-cloud/
I think we should all be taking a hard look at this for a couple of reasons:
Based on this, I think it's something to discuss because it's going to have a big impact on the industry.
http://edicogenome.com/dragen-in-the-cloud/
I think we should all be taking a hard look at this for a couple of reasons:
- These platforms bring it to a wide audience and make it user-friendly
- Platform effects: It's a hardware platform with inherent limits on configurability. This will tend to drive users to stadardize on it and effectively freeze pipelines to this standard.
- It's not available on all platforms.
- It's really fast!
Based on this, I think it's something to discuss because it's going to have a big impact on the industry.
Comment